Total Payments
$5,262
2024 Payments
$1,510
Companies
32
Transactions
324
Medicare Patients
5,507
Medicare Billing
$246,925
Payment Breakdown by Category
Food & Beverage$5,197 (98.8%)
Education$64.95 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,197 | 323 | 98.8% |
| Education | $64.95 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $724.88 | 57 | $0 (2024) |
| ABBVIE INC. | $698.26 | 52 | $0 (2024) |
| GlaxoSmithKline, LLC. | $498.49 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $385.17 | 12 | $0 (2024) |
| Lilly USA, LLC | $357.81 | 21 | $0 (2024) |
| PFIZER INC. | $354.53 | 23 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $278.74 | 15 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $220.01 | 12 | $0 (2024) |
| Amgen Inc. | $218.71 | 14 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $176.43 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,510 | 91 | ABBVIE INC. ($239.91) |
| 2023 | $1,540 | 87 | ABBVIE INC. ($257.21) |
| 2022 | $1,199 | 74 | Novo Nordisk Inc ($286.22) |
| 2021 | $1,012 | 72 | Novo Nordisk Inc ($203.95) |
All Payment Transactions
324 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: VACCINES | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.14 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $1.38 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Obesity | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Cardio-renal | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $0.74 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: VACCINE | ||||||
| 09/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Inflammation | ||||||
| 09/09/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 1,322 | 2,060 | $122,804 | $54,626 |
| 2022 | 30 | 1,291 | 1,797 | $156,597 | $55,084 |
| 2021 | 20 | 1,122 | 1,554 | $193,798 | $61,744 |
| 2020 | 28 | 1,772 | 2,579 | $237,580 | $75,472 |
Total Patients
5,507
Total Services
7,990
Medicare Billing
$246,925
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 280 | $55,560 | $18,813 | 33.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 90 | 90 | $12,060 | $9,262 | 76.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 128 | 360 | $3,960 | $3,024 | 76.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 54 | $7,358 | $2,600 | 35.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 17 | $5,615 | $2,201 | 39.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 25 | 25 | $2,787 | $1,795 | 64.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 112 | 168 | $3,192 | $1,739 | 54.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 81 | 125 | $3,750 | $1,640 | 43.7% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 34 | 40 | $3,000 | $1,618 | 53.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 31 | 33 | $3,852 | $1,124 | 29.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 12 | 18 | $1,570 | $1,094 | 69.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 49 | 65 | $2,015 | $1,070 | 53.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 99 | 140 | $2,100 | $1,065 | 50.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 24 | 35 | $1,890 | $1,015 | 53.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 45 | 100 | $1,800 | $952.00 | 52.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $748.00 | $710.00 | 94.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 13 | 14 | $892.00 | $703.92 | 78.9% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 34 | 52 | $1,404 | $694.72 | 49.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 34 | 39 | $1,092 | $576.42 | 52.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 15 | 32 | $724.00 | $519.04 | 71.7% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 20 | 20 | $680.00 | $378.40 | 55.6% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 22 | 37 | $666.00 | $306.73 | 46.1% |
| 82746 | Folic acid level, serum | Office | 2023 | 17 | 21 | $630.00 | $302.61 | 48.0% |
| 83550 | Iron binding capacity | Office | 2023 | 24 | 30 | $480.00 | $257.10 | 53.6% |
| 83540 | Iron level | Office | 2023 | 29 | 39 | $468.00 | $247.26 | 52.8% |
About Karri Trivett, NP
Karri Trivett, NP is a Family healthcare provider based in Bristol, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2019. The National Provider Identifier (NPI) number assigned to this provider is 1699249060.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Karri Trivett, NP has received a total of $5,262 in payments from pharmaceutical and medical device companies, with $1,510 received in 2024. These payments were reported across 324 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,197).
As a Medicare-enrolled provider, Trivett has provided services to 5,507 Medicare beneficiaries, totaling 7,990 services with total Medicare billing of $246,925. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Family
- Location Bristol, TN
- Active Since 01/18/2019
- Last Updated 01/06/2026
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1699249060
Products in Payments
- TRELEGY ELLIPTA (Drug) $378.23
- VRAYLAR (Drug) $332.41
- XIFAXAN (Drug) $278.74
- Ozempic (Drug) $240.36
- NURTEC ODT (Drug) $220.89
- Kerendia (Drug) $220.01
- BREZTRI (Drug) $214.73
- ELIQUIS (Drug) $213.41
- Rybelsus (Drug) $200.02
- REXULTI (Drug) $199.10
- UBRELVY (Drug) $173.23
- MOUNJARO (Drug) $157.93
- FARXIGA (Drug) $156.43
- Otezla (Drug) $151.29
- JARDIANCE (Drug) $126.99
- QULIPTA (Drug) $109.42
- ENTRESTO (Drug) $107.89
- Wegovy (Drug) $104.75
- SPRAVATO (Drug) $87.93
- Vascepa (Drug) $78.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Bristol
Geoff Szabo, Np, NP
Family — Payments: $12,855
Family $12,855
Kelly Payne, Fnp-C, FNP-C
Family — Payments: $10,956
Family $10,956
Ms. Tamara Pinto, Np-C, NP-C
Family — Payments: $9,345
Family $9,345
Kacy Duncan, Fnp, FNP
Family — Payments: $7,881
Family $7,881
Celeste Sorah
Family — Payments: $5,072
Family $5,072
Brittney Vestal, Fnp, FNP
Family — Payments: $3,552
Family $3,552